Market Analysis

Global Cancer Landscape

Cancer continues to be one of the most significant global health challenges, with nearly 20 million new cases and approximately 10 million deaths reported annually. The global cancer burden is expected to rise steadily over the next two decades due to population aging, urbanization, environmental exposure, and lifestyle-related risk factors.

While therapeutic oncology continues to advance, global evidence strongly supports that early detection and screening remain the most cost-effective and impactful strategies to reduce cancer mortality. As a result, healthcare systems worldwide are shifting focus from late-stage treatment to precision screening and preventive oncology.

Global Early Detection & Screening Market

The global market for early cancer detection and screening is witnessing rapid growth, driven by advancements in molecular diagnostics, liquid biopsy, genomics, AI-assisted imaging, and digital pathology. Multi-cancer early detection tests are emerging as a transformative segment within preventive oncology.

• Rising adoption of AI and machine learning in diagnostic imaging
• Growing demand for minimally invasive screening methods
• Integration of genomics and biomarker-driven risk stratification
• Increased public and private investment in preventive healthcare

India – Cancer Burden & Market Opportunity

India represents one of the fastest-growing cancer markets globally, reporting over 1.4 million new cancer cases annually. The burden is amplified by late-stage diagnosis, limited access to screening, and regional disparities in healthcare delivery.

The Indian cancer diagnostics and screening market is expanding rapidly, supported by government initiatives, public–private partnerships, mobile screening units, and increasing adoption of advanced imaging and molecular testing technologies. India is uniquely positioned to become a global hub for affordable, scalable cancer screening solutions.

Why This Matters for WCC-2027

The 10^th World Cancer Congress – 2027 arrives at a pivotal moment where science, technology, policy, and public health priorities converge. By focusing on early detection, screening, and cancer prevention, WCC-2027 positions itself at the forefront of global oncology transformation.

The congress will act as a strategic platform to connect researchers, clinicians, industry leaders, policymakers, and innovators to accelerate adoption of evidence-based screening models and preventive solutions — especially in high-impact regions such as India.